Cheray, M., Pacaud, R., Nadaradjane, A., Oliver, L., Vallette, F. M., & Cartron, P. (2016). Specific Inhibition of DNMT3A/ISGF3γ Interaction Increases the Temozolomide Efficiency to Reduce Tumor Growth. Theranostics.
Chicago Style CitationCheray, Mathilde, Romain Pacaud, Arulraj Nadaradjane, Lisa Oliver, François M. Vallette, i Pierre-François Cartron. "Specific Inhibition of DNMT3A/ISGF3γ Interaction Increases the Temozolomide Efficiency to Reduce Tumor Growth." Theranostics 2016.
Cita MLACheray, Mathilde, et al. "Specific Inhibition of DNMT3A/ISGF3γ Interaction Increases the Temozolomide Efficiency to Reduce Tumor Growth." Theranostics 2016.
Atenció: Aquestes cites poden no estar 100% correctes.